CannaPharmaRX, Inc.
CPMD
$0.0055
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 312.20K | -- | 25.80K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 312.20K | -- | 25.80K | -- | -- |
| Cost of Revenue | 668.30K | -- | 742.30K | 65.60K | -- |
| Gross Profit | -356.20K | -- | -716.50K | -65.60K | -- |
| SG&A Expenses | 141.80K | 282.30K | 329.70K | -775.10K | 590.90K |
| Depreciation & Amortization | -- | 64.20K | 23.00K | -96.10K | 76.60K |
| Other Operating Expenses | -- | -- | -- | 100.00K | -- |
| Total Operating Expenses | 810.10K | 346.60K | 1.10M | -705.50K | 667.50K |
| Operating Income | -497.90K | -346.60K | -1.07M | 705.50K | -667.50K |
| Income Before Tax | 188.40K | 5.36M | -11.72M | 7.55M | -564.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 188.40K | 5.36M | -11.72M | 7.55M | -564.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 188.40K | 5.36M | -11.72M | 7.55M | -564.40K |
| EBIT | -497.90K | -346.60K | -1.07M | 705.50K | -667.50K |
| EBITDA | -433.70K | -282.30K | -1.05M | 737.50K | -455.50K |
| EPS Basic | 0.00 | 0.01 | -0.03 | 0.02 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.01 | -0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.01 | -0.03 | 0.02 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.01 | -0.02 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 662.50M | 657.98M | 350.52M | 357.74M | 295.10M |
| Average Diluted Shares Outstanding | 662.50M | 657.98M | 350.52M | 357.74M | 295.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
